Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antenatal glucocorticoids and renal function after birth.

T Jahnukainen1, M Chen, U Berg

  • 1Hospital for Children and Adolescents, Helsinki University, Helsinki, Finland.

Seminars in Neonatology : SN
|April 26, 2002
PubMed
Summary

Antenatal glucocorticoid treatment aids fetal lung development. Research suggests these treatments may also permanently alter fetal kidney development, but long-term human effects require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange.

Clinical nephrology·2011
Same author

Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control.

Journal of human hypertension·2010
Same author

IGFBP-1 levels in adult women born small for gestational age suggest insulin resistance in spite of normal BMI.

Journal of internal medicine·2003
Same author

Regulation of K+ transport in the rat distal colon via angiotensin II subtype receptors and K+ -pathways.

Acta physiologica Scandinavica·2001
Same author

Increased blood pressure but normal renal function in adult women born preterm.

Pediatric nephrology (Berlin, Germany)·2001
Same author

Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death.

Proceedings of the National Academy of Sciences of the United States of America·2000

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Pediatric Nephrology

Background:

  • Antenatal glucocorticoid treatment is standard for preterm labor to enhance fetal lung maturation.
  • Evidence suggests prenatal glucocorticoids also promote fetal kidney maturation.
  • Current understanding of glucocorticoid effects on kidney function primarily focuses on short-term outcomes.

Purpose of the Study:

  • To investigate the potential long-term effects of antenatal glucocorticoid treatment on human kidney development and function.
  • To explore whether observed short-term renal maturation effects translate into permanent structural or functional changes.
  • To address the knowledge gap regarding the lasting impact of prenatal corticosteroid exposure on the fetal kidney.

Main Methods:

  • Review of existing human and animal studies on antenatal glucocorticoid exposure.

Related Experiment Videos

  • Analysis of data correlating prenatal glucocorticoid use with neonatal and pediatric renal outcomes.
  • Longitudinal studies tracking renal morphology and function in individuals exposed prenatally.
  • Main Results:

    • Animal studies indicate that antenatal glucocorticoids can induce permanent changes in kidney structure and function.
    • Human studies confirm short-term renal maturation benefits but lack data on long-term consequences.
    • A significant gap exists in understanding the chronic impact of this common obstetric intervention on renal health.

    Conclusions:

    • While beneficial for lung development, antenatal glucocorticoids may pose risks for long-term kidney health.
    • Further research, particularly longitudinal human studies, is crucial to determine the lasting effects of prenatal glucocorticoid exposure on renal outcomes.
    • The potential for permanent renal alterations necessitates careful consideration of the risk-benefit balance in clinical practice.